Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study

• Maria B. Lyng ,

  * E-mail: mlyng@health.sdu.dk (MBL); hditzel@health.sdu.dk (HJD)

  Affiliation Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark

  ⨯
• Anne-Vibeke Lænkholm,

  Affiliation Department of Pathology, Slagelse Hospital, Slagelse, Denmark

  ⨯
• Rolf Søkilde,

  Affiliation Department of Biomarker Discovery, Exiqon A/S, Vedbæk, Denmark

  ⨯
• Karina H. Gravgaard,

  Affiliation Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark

  ⨯
• Thomas Litman,

  Affiliation Department of Biomarker Discovery, Exiqon A/S, Vedbæk, Denmark

  ⨯
• Henrik J. Ditzel

  * E-mail: mlyng@health.sdu.dk (MBL); hditzel@health.sdu.dk (HJD)

  Affiliations Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark, Department of Oncology, Odense University Hospital, Odense, Denmark

  ⨯